Validation of the prognostic value of histopathological grading or c-kit mutation in canine cutaneous mast cell tumours: A retrospective cohort study

Veterinary Journal

Volumn 196, Issue 3, 2013, Pages 492-498

  Takeuchi, Yoshinori ^a,b   Fujino, Yasuhito ^a   Watanabe, Manabu ^c   Takahashi, Masashi ^c   Nakagawa, Takayuki ^a   Takeuchi, Ayano ^b   Bonkobara, Makoto ^d   Kobayashi, Tetsuya ^e   Ohno, Koichi ^a   Uchida, Kazuyuki ^a   Asano, Kazushi ^f   Nishimura, Ryohei ^c   Nakayama, Hiroyuki ^a   Sugano, Sumio ^c   Ohashi, Yasuo ^b   Tsujimoto, Hajime ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d NIPPON VETERINARY AND LIFE SCIENCE UNIVERSITY   (Japan)

^e Japan Small Animal Cancer Center   (Japan)

^f NIHON UNIVERSITY   (Japan)

Author keywords

Dog; Mast cell tumour; Oncology; Prognostic factor; Survival analysis

Indexed keywords

STEM CELL FACTOR;

ANIMAL TISSUE; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER SURVIVAL; CANINE CUTANEOUS MAST CELL TUMOR; COHORT ANALYSIS; DOG DISEASE; EXON; FEMALE; GENE DUPLICATION; GENE MUTATION; HISTOPATHOLOGY; LYMPH NODE METASTASIS; MALE; NONHUMAN; ONCOGENE C KIT; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; SURVIVAL RATE;

ANIMALS; COHORT STUDIES; DOG DISEASES; DOGS; FEMALE; MALE; MASTOCYTOMA; PREDICTIVE VALUE OF TESTS; PROTO-ONCOGENE PROTEINS C-KIT; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SKIN NEOPLASMS;

CANIS FAMILIARIS;

EID: 84879415533     PISSN: 10900233     EISSN: 15322971     Source Type: Journal    
DOI: 10.1016/j.tvjl.2012.11.018     Document Type: Article

References (28)

1. Dobson J.M., Scase T.J. Advances in the diagnosis and management of cutaneous mast cell tumours in dogs. Journal of Small Animal Practice 2007, 48:424-431.
2. Downing S., Chien M.B., Kass P.H., Moore P.E., London C.A. Prevalence and importance of internal tandem duplications in exons 11 and 12 of c-kit in mast cell tumors of dogs. American Journal of Veterinary Research 2002, 63:1718-1723.
3. Isotani M., Ishida N., Tominaga M., Tamura K., Yagihara H., Ochi S., Kato R., Kobayashi T., Fujita M., Fujino Y., et al. Effect of tyrosine kinase inhibition by imatinib mesylate on mast cell tumors in dogs. Journal of Veterinary Internal Medicine 2008, 22:985-988.
4. Kiupel M., Webster J.D., Kaneene J.B., Miller R., Yuzbasiyan-Gurkan V. The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors. Veterinary Pathology 2004, 41:371-377.
5. Kiupel M., Webster J.D., Bailey K.L., Best S., DeLay J., Detrisac C.J., Fitzgerald S.D., Gamble D., Ginn P.E., Goldschmidt M.H., et al. Proposal of a 2-tier histologic grading system for canine cutaneous mast cell tumors to more accurately predict biological behavior. Veterinary Pathology 2011, 48:147-155.
6. Krick E.L., Billings A.P., Shofer F.S., Watanabe S., Sorenmo K.U. Cytological lymph node evaluation in dogs with mast cell tumours: Association with grade and survival. Veterinary and Comparative Oncology 2009, 7:130-138.
7. Letard S., Yang Y., Hanssens K., Palmerini F., Leventhal P.S., Guery S., Moussy A., Kinet J.P., Hermine O., Dubreuil P. Gain-of-function mutations in the extracellular domain of KIT are common in canine mast cell tumors. Molecular Cancer Research 2008, 6:1137-1145.
8. London C.A., Galli S.J., Yuuki T., Hu Z.Q., Helfand S.C., Geissler E.N. Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene c-kit. Experimental Hematology 1999, 27:689-697.
9. Ma Y., Longley B.J., Wang X., Blount J.L., Langley K., Caughey G.H. Clustering of activating mutations in c-KIT's juxtamembrane coding region in canine mast cell neoplasms. Journal of Investigative Dermatology 1999, 112:165-170.
10. Murphy S., Sparkes A.H., Smith K.C., Blunden A.S., Brearley M.J. Relationships between the histological grade of cutaneous mast cell tumours in dogs, their survival and the efficacy of surgical resection. Veterinary Record 2004, 154:743-746.
11. Northrup N.C., Howerth E.W., Harmon B.G., Brown C.A., Carmichael K.P., Garcia A.P., Latimer K.S., Munday J.S., Rakich P.M., Richey L.J., et al. Variation among pathologists in the histologic grading of canine cutaneous mast cell tumors with uniform use of a single grading reference. Journal of Veterinary Diagnostic Investigation 2005, 17:561-564.
12. Ohmori K., Kawarai S., Yasuda N., Tanaka A., Matsuda H., Nishimura R., Sasaki N., Tsujimoto H., Masuda K. Identification of c-kit mutations-independent neoplastic cell proliferation of canine mast cells. Veterinary Immunology and Immunopathology 2008, 126:43-53.
13. Patnaik A.K., Ehler W.J., MacEwen E.G. Canine cutaneous mast cell tumor: Morphologic grading and survival time in 83 dogs. Veterinary Pathology 1984, 21:469-474.
14. Preziosi R., Sarli G., Paltrinieri M. Multivariate survival analysis of histological parameters and clinical presentation in canine cutaneous mast cell tumours. Veterinary Research Communications 2007, 31:287-296.
15. Pryer N.K., Lee L.B., Zadovaskaya R., Yu X., Sukbuntherng J., Cherrington J.M., London C.A. Proof of target for SU11654: Inhibition of KIT phosphorylation in canine mast cell tumors. Clinical Cancer Research 2003, 9:5729-5734.
16. Roskoski R. Structure and regulation of Kit protein-tyrosine kinase - The stem cell factor receptor. Biochemical and Biophysical Research Communications 2005, 338:1307-1315.
17. Scase T.J., Edwards D., Miller J., Henley W., Smith K., Blunden A., Murphy S. Canine mast cell tumors: Correlation of apoptosis and proliferation markers with prognosis. Journal of Veterinary Internal Medicine 2006, 20:151-158.
18. Strefezzi R.F., Xavier J.G., Catao-Dias J.L. Morphometry of canine cutaneous mast cell tumors. Veterinary Pathology 2003, 40:268-275.
19. Takeuchi Y., Fujino Y., Watanabe M., Nakagawa T., Ohno K., Sasaki N., Sugano S., Tsujimoto H. Aberrant autophosphorylation of c-Kit receptor in canine mast cell tumor cell lines. Veterinary Immunology and Immunopathology 2010, 137:208-216.
20. Thamm D.H., Vail D.M. Mast cell tumors. Small Animal Clinical Oncology 2007, 425-454. Saunders Elsevier, St. Louis, MO, USA. Fourth Ed.
21. Tsai K.L., Guyon R., Murphy K.E. Identification of isoforms and RH mapping of canine KIT. Cytogenetic and Genome Research 2003, 102:261-263.
22. Vascellari, M., Giantin, M., Capello, K., Carminato, A., Morello, E.M., Vercelli, A., Granato, A., Buracco, P., Dacasto, M., Mutinelli, F., 2012. Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: Association with grading and prognosis. Veterinary Pathology (June 6) [Epub ahead of print].
23. Webster J.D., Kiupel M., Yuzbasiyan-Gurkan V. Evaluation of the kinase domain of c-KIT in canine cutaneous mast cell tumors. BMC Cancer 2006, 6:85.
24. Webster J.D., Yuzbasiyan-Gurkan V., Kaneene J.B., Miller R., Resau J.H., Kiupel M. The role of c-KIT in tumorigenesis: Evaluation in canine cutaneous mast cell tumors. Neoplasia 2006, 8:104-111.
25. Webster J.D., Yuzbasiyan-Gurkan V., Thamm D.H., Hamilton E., Kiupel M. Evaluation of prognostic markers for canine mast cell tumors treated with vinblastine and prednisone. BMC Veterinary Research 2008, 4:32.
26. Webster, J.D., Dennis, M.M., Dervisis, N., Heller, J., Bacon, N.J., Bergman, P.J., Bienzle, D., Cassali, G., Castagnaro, M., Cullen, J., Esplin, D.G., Peña, L., Goldschmidt, M.H., Hahn, K.A., Henry, C.J., Hellmén, E., Kamstock, D., Kirpensteijn, J., Kitchell, B.E., Amorim, R.L., Lenz, S.D., Lipscomb, T.P., McEntee, M., McGill, L.D., McKnight, C.A., McManus, P.M., Moore, A.S., Moore, P.F., Moroff, S.D., Nakayama, H., Northrup, N.C., Sarli, G., Scase, T., Sorenmo, K., Schulman, F.Y., Shoieb, A.M., Smedley, R.C., Spangler, W.L., Teske, E., Thamm, D.H., Valli, V.E., Vernau, W., von Euler, H., Withrow, S.J., Weisbrode, S.E., Yager, J., Kiupel, M., American College of Veterinary Pathologists' Oncology Committee, 2011. Recommended guidelines for the conduct and evaluation of prognostic studies in veterinary oncology. Veterinary Pathology 48, 7-18.
27. Welle M.M., Bley C.R., Howard J., Rufenacht S. Canine mast cell tumours: A review of the pathogenesis, clinical features, pathology and treatment. Veterinary Dermatology 2008, 19:321-339.
28. Zemke D., Yamini B., Yuzbasiyan-Gurkan V. Mutations in the juxtamembrane domain of c-KIT are associated with higher grade mast cell tumors in dogs. Veterinary Pathology 2002, 39:529-535.